Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug-induced DNA hypermethylation: a potential mediator of acquired drug resistance during cancer chemotherapy.

× No keyword cloud information.

18 in total

Review 1. Interstrand crosslink inducing agents in pretransplant conditioning therapy for hematologic malignancies.

Authors: Benigno C Valdez; Borje S Andersson
Journal: Environ Mol Mutagen Date: 2010-07 Impact factor: 3.216

2. 5-Aza-2'-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis.

Authors: Benigno C Valdez; Yang Li; David Murray; Paul Corn; Richard E Champlin; Borje S Andersson
Journal: Leuk Res Date: 2009-09-03 Impact factor: 3.156

3. Gemcitabine functions epigenetically by inhibiting repair mediated DNA demethylation.

Authors: Andrea Schäfer; Lars Schomacher; Guillermo Barreto; Gabi Döderlein; Christof Niehrs
Journal: PLoS One Date: 2010-11-19 Impact factor: 3.240

4. Predictive value of CHFR and MLH1 methylation in human gastric cancer.

Authors: Yazhuo Li; Yunsheng Yang; Youyong Lu; James G Herman; Malcolm V Brock; Po Zhao; Mingzhou Guo
Journal: Gastric Cancer Date: 2014-04-21 Impact factor: 7.370

5. DNA methylation patterns of adult survivors of adolescent/young adult Hodgkin lymphoma compared to their unaffected monozygotic twin.

Authors: Jun Wang; David Van Den Berg; Amie E Hwang; Daniel Weisenberger; Timothy Triche; Bharat N Nathwani; David V Conti; Kim Siegmund; Thomas M Mack; Steve Horvath; Wendy Cozen
Journal: Leuk Lymphoma Date: 2019-01-22

6. DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells.

Authors: Myrna Candelaria; Erick de la Cruz-Hernandez; Lucia Taja-Chayeb; Enrique Perez-Cardenas; Catalina Trejo-Becerril; Aurora Gonzalez-Fierro; Alma Chavez-Blanco; Ernesto Soto-Reyes; Guadalupe Dominguez; Jaenai E Trujillo; Jose Diaz-Chavez; Alfonso Duenas-Gonzalez
Journal: PLoS One Date: 2012-03-12 Impact factor: 3.240

Drug-induced DNA hypermethylation: a potential mediator of acquired drug resistance during cancer chemotherapy.

Review 1. Interstrand crosslink inducing agents in pretransplant conditioning therapy for hematologic malignancies.

2. 5-Aza-2'-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis.

3. Gemcitabine functions epigenetically by inhibiting repair mediated DNA demethylation.

4. Predictive value of CHFR and MLH1 methylation in human gastric cancer.

5. DNA methylation patterns of adult survivors of adolescent/young adult Hodgkin lymphoma compared to their unaffected monozygotic twin.

6. DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells.

Review 7. Epigenetics of cervical cancer. An overview and therapeutic perspectives.

8. Can the state of cancer chemotherapy resistance be reverted by epigenetic therapy?

Review 9. Imprinted genes as potential genetic and epigenetic toxicologic targets.

10. The role of epigenetics in resistance to Cisplatin chemotherapy in lung cancer.